He was trained in toxicology and epidemiology. His research focuses on late effects (mainly treatment-induced cardiovascular disease and secondary cancer) after radiotherapy and chemotherapy as treatment for breast cancer, testicular cancer and (Hodgkin) lymphoma, return to work issues after breast cancer treatment, and risk of (ipsilateral) invasive breast cancer after ductal carcinoma in situ of the breast.